ID   SK-N-BE(1)n
AC   CVCL_A8RV
SY   SKNBE(1)N; SKNBE(1n); SKNBE1n
DR   IARC_TP53; 23829
DR   Wikidata; Q108821307
RX   PubMed=2535691;
RX   PubMed=11196202;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Karyotypic information: 46,XY,del(1)(p32),der(3)t(3;17)(p21;q21),der(4)t(1;4)(q21;q3?5),dmin (PubMed=11196202).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11196202).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9898 ! SK-N-BE(1)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
RX   PubMed=2535691;
RA   Ciccarone V.C., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A.;
RT   "Phenotypic diversification in human neuroblastoma cells: expression
RT   of distinct neural crest lineages.";
RL   Cancer Res. 49:219-225(1989).
//
RX   PubMed=11196202;
RA   Tweddle D.A., Malcolm A.J., Bown N., Pearson A.D.J., Lunec J.;
RT   "Evidence for the development of p53 mutations after cytotoxic therapy
RT   in a neuroblastoma cell line.";
RL   Cancer Res. 61:8-13(2001).
//
RX   PubMed=15720811; DOI=10.1593/neo.04310; PMCID=PMC1531688;
RA   Walton J.D., Kattan D.R., Thomas S.K., Spengler B.A., Guo H.-F.,
RA   Biedler J.L., Cheung N.-K.V., Ross R.A.;
RT   "Characteristics of stem cells from human neuroblastoma cell lines and
RT   in tumors.";
RL   Neoplasia 6:838-845(2004).
//
RX   PubMed=26342562; DOI=10.1016/j.scr.2015.08.008; PMCID=PMC4601571;
RA   Ross R.A., Walton J.D., Han D., Guo H.-F., Cheung N.-K.V.;
RT   "A distinct gene expression signature characterizes human
RT   neuroblastoma cancer stem cells.";
RL   Stem Cell Res. 15:419-426(2015).
//